← All stocks

GLOBUS MEDICAL INC

GMED Net selling

CIK 0001237831 #875 in the set updated 17 Sep 2026

Bought (120 mo)

$99.82K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$346.79M

$11.62M on a plan · $317.41M straight out of an exercise

Sold at will

$17.76M

16 of 139 sales

Net

−$346.69M

−$17.66M against sales at will

By person

19 insiders · 149 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Paul David C

Executive Chairman

—

$154.62M (18) scheduled

−$154.62M

60,417

0.0450%

$4.51M

−94.4%

Demski David M

President, CEO

—

$61.74M (16) scheduled

−$61.74M

0.0000%

$0.00

−100.0%

Scavilla Daniel T

President, CEO

—

$34.20M (8) scheduled

−$34.20M

0.0000%

$0.00

—

Davidar David D

Director

—

$30.21M (22) scheduled

−$30.21M

673,642

0.5017%

$50.24M

−29.8%

Williams Anthony L

President

—

$17.85M (7) scheduled

−$17.85M

0.0000%

$0.00

—

Lemaitre Dan

Director

—

$8.75M (5) scheduled

−$8.75M

0.0000%

$0.00

—

TOBIN JAMES R

Director

—

$8.67M (11) scheduled

−$8.67M

0.0000%

$0.00

—

Huller Kelly

EVP, GC, Corporate Secretary

—

$8.05M (21) scheduled

−$8.05M

0.0000%

$0.00

−100.0%

Pfeil Keith W

President, CEO

—

$6.21M (9) scheduled

−$6.21M

0.0000%

$0.00

—

ZARRILLI STEPHEN T

Director

—

$4.28M (2) scheduled

−$4.28M

0.0000%

$0.00

—

RHOADS ANN D

Director

—

$3.05M (5) scheduled

−$3.05M

40,384

0.0301%

$3.01M

—

Murphy A Brett

EVP, International Sales

—

$2.76M (3)

−$2.76M

35,217

0.0262%

$2.63M

−69.7%

Kline Kyle

Senior Vice President, CFO

—

$2.03M (2) scheduled

−$2.03M

0.0000%

$0.00

—

Schwartz Eric

Senior VP and General Counsel

—

$1.74M (3) scheduled

−$1.74M

0.0000%

$0.00

—

Payne Steven

Chief Accounting Officer

—

$1.45M (3)

−$1.45M

0.0000%

$0.00

−100.0%

Norwalk Leslie V

Director

—

$1.18M (4) scheduled

−$1.18M

10,419

0.0078%

$777.08K

—

Douglas Robert Andrew

Director

$99.82K (3)

—

+$99.82K

2,005

0.0015%

$149.54K

—

Wolterman Dan

Director

—

24,025

0.0179%

$1.79M

—

DeFord John A

Director

—

15,578

0.0116%

$1.16M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Davidar David D

19 Apr 2022

Director

Sell

31,500

$78.03

$2.46M

Davidar David D

24 Nov 2020

Director

Sell indirect

10,000

$60.00

$600.00K

Davidar David D

24 Nov 2020

Director

Sell

32,000

$60.00

$1.92M

Huller Kelly

7 Nov 2019

SVP, General Counsel

Sell

3,000

$55.90

$167.70K

Davidar David D

7 Nov 2019

Director

Sell indirect

10,000

$54.04

$540.40K

Davidar David D

7 Nov 2019

Director

Sell

38,000

$54.00

$2.05M

Huller Kelly

1 Nov 2019

SVP, General Counsel

Sell

3,000

$52.90

$158.70K

Huller Kelly

2 Aug 2019

SVP, General Counsel

Sell

3,000

$49.90

$149.70K

Huller Kelly

28 Mar 2019

SVP, General Counsel

Sell

3,000

$48.59

$145.77K

Paul David C

17 Jul 2018

Executive Chairman

Sell

6,841

$52.95

$362.23K

Payne Steven

31 May 2018

Chief Accounting Officer

Sell

20,771

$55.81

$1.16M

Paul David C

30 Apr 2018

Executive Chairman

Sell

72,938

$51.81

$3.78M

Paul David C

27 Apr 2018

Executive Chairman

Sell

29,066

$51.78

$1.51M

Murphy A Brett

10 Nov 2017

Group President, Commerical Op

Sell

14,551

$35.00

$509.29K

Murphy A Brett

9 Nov 2017

Group President, Commerical Op

Sell

51,449

$35.00

$1.80M

Murphy A Brett

6 Sep 2017

President, Commerical Op

Sell

15,000

$29.99

$449.90K

Show all 149 transactions →

What was left out

Form 4 filings counted 233

Amendments (4/A) skipped 4

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 15

Sales straight out of an exercise 108

Sales at will 16

Transactions with no price 0

Shares from compensation/vesting 4,606,089

Sales filed before the plan box existed 16

History held since 1 Feb 2017